ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: 51 kDa FK506-binding protein; 52 kDa FK506-binding protein; 52 kDa FKBP; 59 kDa immunophilin; FK506-binding protein 4; FKBP-4; FKBP-52; FKBP51; FKBP59; HBI; HSP-binding immunophilin; Immunophilin FKBP52; PPIase FKBP4; Peptidyl-prolyl cis-trans isomerase FKBP4; Rotamase; p59
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected FKBP52 in HEK293, NIH3T3, and L6 cell lysates.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected FKBP52 in A431 and HepG2 cells.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected FKBP52 in human testis tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany